Painkiller interference tested on new diabetes sensor
NCT ID NCT06560177
First seen Feb 16, 2026 · Last updated May 15, 2026 · Updated 14 times
Summary
This study checked whether acetaminophen (Tylenol) interferes with a new continuous glucose monitor (CGM) called Biolinq. 31 adults with diabetes wore the Biolinq sensor and a standard CGM for three days. On the third day, they took acetaminophen and had their blood sugar measured to see if the sensor's readings stayed accurate. The goal was to ensure the device works reliably even when users take common pain relievers.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Rocky Mountain Clinical Research
Idaho Falls, Idaho, 83404, United States
Conditions
Explore the condition pages connected to this study.